ICyte Platform December 1, 2022 Entering the New Era of Data-Driven Drug Commercialization 5 Minute Read Co-Founder and Chief Operating Officer Josh Halpern reviews key industry trends impacting product commercialization and access, including the shift to true data-driven commercialization, highlighted at the Access Insights Conference...
ICyte Platform March 7, 2022 Unifying IntegriChain’s Services & Support: Customer Support and Value Realization 4 Minute Read In his second unification-focused blog, President and COO Josh Halpern discusses IntegriChain's investment in customer support to better augment the value for customers and end-users.
ICyte Platform February 15, 2022 Unifying IntegriChain’s Services & Support: Data Management 4 Minute Read President and COO Josh Halpern discusses the current and future capabilities of the integrated applications, analytics, and datastores within the ICyte Platform.
ICyte Platform November 23, 2021 A Look Back at the 2021 Access Insights Conference 2 Minute Read Co-founder and EVP Josh Halpern reviews the recent Access Insights Conference and some of the key challenges that Life Sciences market access teams face.
ICyte Platform October 29, 2021 15 Years Strong 2 Minute Read Founder and CEO Kevin Leininger celebrates IntegriChain's outstanding customers and our team of professionals around the globe on our 15th anniversary.
ICyte Platform July 8, 2021 Breaking down the Silos for Next-Generation Access 5 Minute Read This blog is the fourth in a series that shares our vision for future-proofing Market Access. Manufacturers can evolve the Market Access function to work toward their commercial, financial, and...
ICyte Platform June 17, 2021 Operational Goals to Future Proof Market Access 3 Minute Read In this third installment, we look at operational goals for Market Access. Commercial Operations and Contracting teams need a flexible infrastructure that can support business scale and the changing...
ICyte Platform June 3, 2021 Financial Goals to Future Proof Market Access 3 Minute Read In this four-part series, we examine the key goals of Market Access teams as they look to the future with the advent of speciality and precision medicine and how...
ICyte Platform May 20, 2021 Future Proofing Market Access with a Unified Data and Technology Platform 4 Minute Read This is the first of a series examining the commercial, financial, and operational goals of Market Access, which are all are stymied by data and application silos.
